Yahoo · Nov 9, 2026
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
WESTLAKE VILLAGE, Calif., November 09, 2026--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory and infectious skin diseases, today provided corporate updates and reported financial results for the three and nine months ended September 30, 2026.

